Metal-free Aortic Valve Shows Promise in Early Clinical Trials

The new prosthetic valve appears to reduce the risk of aortic regurgitation, which can be a problem after replacement heart valves are implanted.

A prosthetic aortic valve that contains no metallic components demonstrated safety and effectiveness in an early trial. Led by Cleveland Clinic cardiologist Murat Tuzcu, MD, the study of the Direct Flow Medical system resulted in low rates of mortality and stroke, as well as minimal aortic regurgitation.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access